Long non-coding RNAs: How to regulate the metastasis of non-small-cell lung cancer.
Cheng FangLixin WangChenyuan GongWenbin WuChao YaoShiguo ZhuPublished in: Journal of cellular and molecular medicine (2020)
Non-small-cell lung cancer (NSCLC) has become the most lethal human cancer because of the high rate of metastasis. Hence, clarifying the molecular mechanism underlying NSCLC metastasis is very important to improve the prognosis of patients with NSCLC. Long non-coding RNAs (LncRNAs) are a class of RNA molecules longer than 200 nucleotides, which can participate in diverse biological processes. About 18% of human LncRNAs were recently found to be associated with tumours. Many studies indicated that aberrant expression of LncRNAs played key roles in the progression and metastasis of NSCLC. According to the function in tumours, LncRNAs can be divided into two classes: oncogenic LncRNAs and tumour-suppressor LncRNAs. In this review, we summarized the main molecular mechanism of LncRNAs regulating NSCLC metastasis, including three aspects: (a) LncRNAs interact with miRNAs as ceRNAs; (b) LncRNAs bind with target proteins; and (c) LncRNAs participate in the transduction of different signal pathways. Then, LncRNAs can exert their function to regulate the metastasis of NSCLC through influencing the progression of epithelial-mesenchymal transition (EMT) and the properties of cancer stem cell (CSC). But, it is necessary to do some further research to demonstrate the LncRNAs particular regulatory mechanism of inhibiting the metastasis of NSCLC and explore new drugs targeting LncRNAs.
Keyphrases
- small cell lung cancer
- network analysis
- long non coding rna
- genome wide analysis
- genome wide identification
- advanced non small cell lung cancer
- epithelial mesenchymal transition
- poor prognosis
- endothelial cells
- transcription factor
- squamous cell carcinoma
- drug delivery
- transforming growth factor
- squamous cell
- cancer therapy